Latest On Zealand Pharma A/S (ZLDPF):
About Zealand Pharma A/S (ZLDPF):
Zealand Pharma A/S, a biotechnology company, engages in the discovery and development of peptide-based medicines in Denmark. It has a portfolio of medicines in development stage focusing on gastrointestinal and metabolic diseases. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes glepaglutide, a long acting GLP-2 analog, which is in Phase 3 clinical trials for the treatment of short bowel syndrome; and dasiglucagon, a stable glucagon analog for the treatment of severe hypoglycemia in diabetes and congenital hyperinsulinism, as well as for use in dual-hormone artificial pancreas for automated diabetes management. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; and Beta Bionics, Inc. to initiate home-use trial of the iLet bionic pancreas with dasiglucagon for autonomous bihormonal treatment of type 1 diabetes, as well as research agreement with Orbit Discovery Ltd. and Torrey Pines Institute for Molecular Studies. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.
General
- Name Zealand Pharma A/S
- Symbol ZLDPF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryBiotechnology
- Full Time Employees 329
- Fiscal Year EndDecember
- Web URLhttp://www.zealandpharma.com
Valuation
- Price/Sales (Trailing 12 Mt.) 21.43
- Price/Book (Most Recent Quarter) 7.27
- Enterprise Value Revenue 3.26
Financials
- Most Recent Quarter 2020-12-31
- Profit Margin -240%
- Return on Assets -30%
- Return on Equity -69%
- Revenue Per Share $0
- Gross Profit 262.75 million
- Quarterly Earnings Growth 451.3%
Highlights
- Market Capitalization 1.32 billion
- Analyst Target Price $35.25
Share Statistics
- Shares Outstanding 43.34 million
- Shares Float 30.68 million
- % Held by Insiders 10%
- % Held by Institutions 58.65%
Technicals
- Beta 0.94
- 52 Week High $42.3
- 52 Week Low $24.6
- 50 Day Moving Average 32.98
- 200 Day Moving Average 35.91
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Zealand Pharma A/S (ZLDPF) Dividend Calendar:
Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
---|
Zealand Pharma A/S (ZLDPF) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
---|---|---|---|---|---|
2020-12-31 | 2020-12-31 | $N/A | -$1.53 | ||
2020-09-30 | 2020-11-12 | $N/A | -$5.76 | ||
2020-06-30 | 2020-09-30 | $N/A | -$0.91 | ||
2020-03-31 | 2020-06-30 | $12.42 million | -$0.24 | ||
2019-12-31 | 2020-03-31 | $11.49 million | -$0.74 | ||
2019-09-30 | 2019-12-31 | $9.92 million | -$0.80 | ||
2019-06-30 | 2019-09-30 | $19.92 million | -$0.50 | ||
2019-03-31 | 2019-06-30 | $N/A | -$0.66 | ||
2018-12-31 | 2019-03-31 | $2.01 million | -$0.62 | ||
2018-09-30 | 2018-12-31 | $N/A | -$0.65 | ||
2018-06-30 | 2018-09-30 | $2.36 million | $4.66 | ||
2018-03-31 | 2018-06-30 | $1.61 million | -$0.56 | ||
2017-12-31 | 2018-03-31 | $1.82 million | -$0.52 | ||
2017-09-30 | 2017-12-31 | $6.32 million | -$0.56 | -$2.23 | 75.03% |
2017-06-30 | 2017-09-30 | -$0.24 | |||
2017-03-31 | 2017-06-30 | -$0.57 | -$0.90 | 37.02% | |
2016-12-31 | 2017-03-31 | -$0.15 | |||
2016-09-30 | 2016-12-31 | $0.29 | $0.45 | -35.04% | |
2016-06-30 | 2016-09-30 | -$0.19 | -$3.52 | 94.47% | |
2016-03-31 | 2016-06-30 | -$0.61 | -$2.96 | 79.32% | |
2015-12-31 | 2016-03-31 | -$0.50 | $4.21 | -111.88% | |
2015-09-30 | 2015-12-31 | $0.41 | -$2.36 | 117.39% | |
2015-06-30 | 2015-09-30 | -$0.33 | -$1.76 | 81.21% | |
2015-03-31 | 2015-06-30 | -$0.51 | -$2.00 | 74.62% | |
2014-12-31 | 2015-03-31 | -$0.34 | -$2.70 | 87.33% | |
2014-09-30 | 2014-12-31 | -$0.43 | -$0.40 | -7.28% | |
2014-06-30 | 2014-09-30 | $0.13 | -$2.00 | 106.28% | |
2014-03-31 | 2014-06-30 | -$0.39 | $0.00 | ||
2013-12-31 | 2014-03-31 | $0.23 | $0.00 | ||
2013-09-30 | 2013-12-31 | -$0.36 | $0.00 | ||
2013-06-30 | 2013-09-30 | -$0.28 | $0.00 | ||
2013-03-31 | 2013-06-30 | -$0.36 | $0.00 | ||
2012-12-31 | 2013-03-31 | -$0.43 | $0.00 | ||
2012-09-30 | 2012-12-31 | -$0.41 | $0.00 | ||
2012-06-30 | 2012-09-30 | -$0.01 | $0.00 | ||
2012-03-31 | 2012-06-30 | $0.18 | $0.00 | ||
2011-12-31 | 2012-03-31 | $0.52 | $0.00 | ||
2011-09-30 | 2011-12-31 | -$0.15 | $0.00 | ||
2011-06-30 | 2011-09-30 | -$0.12 | $0.00 | ||
2011-03-31 | 2011-06-30 | $0.79 | $0.00 | ||
2010-12-31 | 2011-03-31 | -$0.26 | $0.00 | ||
2010-09-30 | 2010-12-31 | -$0.53 | $0.00 |
Zealand Pharma A/S (ZLDPF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
Date |
---|
Research Development |
Income Before Tax |
Selling General Administrative |
Gross Profit |
Ebit |
Operating Income |
Income Tax Expense |
Total Revenue |
Cost of Revenue |
Total Other Income Expense Net |
Net Income From Continuing Operations |
Net Income Applicable to Common Shares |
Cash Flow:
Date |
---|
Investments |
Change to Liabilities |
Total Cash Flow from Investing Activities |
Net Borrowings |
Total Cash Flow from Financial Activities |
Change to Operating Activities |
Change in Cash |
Total Cash from Operating Activities |
Depreciation |
Other Cash Flow from Investing Activities |
Change to Inventory |
Change to Account Receivables |
Other Cash Flow from Financing Activities |
Change to Net Income |
Capital Expenditures |
Balance Sheet:
Date |
---|
Total Liabailities |
Total Stockholder Equity |
Other Current Liabilities |
Total Assets |
Common Stock |
Other Current Assets |
Retained Earnings |
Other Liabilities |
Other Assets |
Cash |
Total Current Liabilities |
Other Stockholder Equity |
Property, Plant & Equipment |
Total Current Assets |
Long Term Investments |
Net Tangible Assets |
Short Term Investments |
Long Term Debt |
Inventory |
Accounts Payable |
Zealand Pharma A/S (ZLDPF) Chart:
Zealand Pharma A/S (ZLDPF) News:
Below you will find a list of latest news for Zealand Pharma A/S (ZLDPF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Zealand Pharma A/S (ZLDPF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
---|
Zealand Pharma A/S (ZLDPF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
Date | Form Type | Form Name | Link |
---|